miR-190 enhances endocrine therapy sensitivity by regulating SOX9 expression in breast cancer

BACKGROUND: Breast cancer is the most common cancer among women worldwide, and approximately 70% of breast cancers are hormone receptor-positive and express estrogen receptor-α (ERα) or/and progesterone receptor. Therapies targeting ERα have been successfully used in patients with ERα(+) breast canc...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Yue, Yin, Wen, Yu, Zhi-Hao, Zhou, Yan-Jun, Chi, Jiang-Rui, Ge, Jie, Cao, Xu-Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6339391/
https://www.ncbi.nlm.nih.gov/pubmed/30658681
http://dx.doi.org/10.1186/s13046-019-1039-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6339391/
https://www.ncbi.nlm.nih.gov/pubmed/30658681
http://dx.doi.org/10.1186/s13046-019-1039-9

Ejemplares similares